“…prevention and treatment of patients with immune platelet disorders and for the provision of compatible blood products from HPA-typed donor panel populations. Currently, DNA-based methods have been widely used for HPA genotyping [8][9][10][11][12][13], such as PCR sequence-specific primers (PCR-SSP) [8], PCR sequence-based typing (PCR-SBT) [9], BeadChip Microarray Technology [10], real-time PCR [11], matrix-assisted laser desorption/ionization time-of-flight mass spectrometry [12,13]. We have also reported a PCR-SBT assay combining with high-throughput DNA sequencer for identifying the genotypes of HPA-1 to 17w systems [14].…”